XML 91 R79.htm IDEA: XBRL DOCUMENT v3.26.1
Earnings Per Share - Basic and Diluted Net loss Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Net loss per ImmunityBio common share – basic and diluted        
Net loss attributable to ImmunityBio common stockholders $ (230,378) $ (92,555) $ (863,160) $ (222,201)
Net loss attributable to ImmunityBio common stockholders $ (230,378) $ (92,555) $ (863,160) $ (222,201)
Weighted-average number of common shares outstanding - basic (in shares) 1,050,070 888,216 1,038,536 870,786
Weighted-average number of common shares used in computing net loss per share – diluted (in shares) 1,050,070 888,216 1,038,536 870,786
Net loss per ImmunityBio common share – basic (in dollars per share) $ (0.22) $ (0.10) $ (0.83) $ (0.26)
Net loss per ImmunityBio common share - diluted (in dollars per share) $ (0.22) $ (0.10) $ (0.83) $ (0.26)